Atherectomy Devices Market by Type, Application & End User - 2022


Posted November 7, 2017 by Sandeepguha21

Atherectomy Devices Market – by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User

 
‘Atherectomy Devices Market – by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User (Hospitals, Surgical Centers, ASCs, Research Laboratories, Academic Institutes)–Global Forecasts to 2022’
http://www.marketsandmarkets.com/Market-Reports/atherectomy-devices-market-133112140.html
MarketsandMarkets: Atherectomy Devices Market is Projected to Reach USD 1.45 Billion by 2022.

The report studies the global atherectomy devices market over the forecast period of 2017 to 2022. The market is projected to reach USD 1.45 billion by 2022 from USD 1.08 billion in 2017, at a CAGR of 6.1%. Factors such as favorable reimbursement scenario for atherectomy procedures, increasing number of research activities in the field of atherectomy, and increasing healthcare expenditure are driving the growth of the market.

Browse 66 market data tables and 26 figures spread through XX pages and in-depth TOC on “Atherectomy Devices Market– Global Forecasts to 2022.”

Early buyers will receive a 10% customization on the report.

Based on product, the directional atherectomy devices segment is expected to witness the highest growth during the forecast period.

On the basis of product, the atherectomy devices market is categorized into directional, orbital, photo-ablative (laser), rotational atherectomy devices, and support devices. In 2017, the directional atherectomy devices segment accounted for the largest share of the market. It is also expected to register the highest CAGR during the forecast period. This can be attributed to clinical benefits offered (such as lack of barotrauma, less risk of neointimal hyperplasia, immediate change of bypass site, and availability of differently sized instruments to enable atherectomy in blood vessels) and ongoing technological advancements in the field of directional atherectomy.

Download PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=133112140

Based on application, the peripheral vascular applications segment is estimated to have the largest share of the market in 2017.

Based on application, the market is categorized into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular applications segment accounted for the major share of the market owing to the significant availability of clinical evidence to support the therapeutic efficacy of atherectomy in PVD treatment and growing patient preference for minimally invasive surgical procedures.

Based on end user, the hospitals and surgical centers segment is expected to witness the highest growth during the forecast period.

Based on end user, the market is segmented into hospitals & surgical centers, ambulatory care centers, and research laboratories & academic institutes. The hospitals and surgical centers segment is expected to register the highest CAGR during the forecast period. The large share of this segment is attributed to increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, rising incidence of chronic vascular diseases, and growing availability of healthcare reimbursements across major countries.
Request Sample: http://www.marketsandmarkets.com/requestsample.asp?id=133112140
North America is expected to dominate the atherectomy devices market in 2017.

Geographically, the market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. North America is expected to account for the largest share of the market in 2017, followed by Europe. Factors such as increasing availability of reimbursements for atherectomy devices, growing adoption of atherectomy devices among medical professionals, large patient population of peripheral & coronary artery diseases, and growing number of clinical trials are driving the growth of the North American atherectomy devices market. However, Asia Pacific is expected to register the highest growth rate during the forecast period. This can be attributed to the increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems (less revascularization rates, high efficacy, short procedural time).

Major players operating in the market are Medtronic (Ireland), Philips (Netherlands), Boston Scientific (US), and Cardiovascular Systems (US). Other prominent players present in this market include Straub Medical (Switzerland), BIOTRONIK (Netherlands), C.R. Bard (US), and Avinger (US).

“Brief information on Research methodology for the report can be found in the report description provided on the website.”
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Mr. Rohan
Website MarketsandMarkets™
Phone 1-888-600-6441
Business Address Mr. Rohan MarketsandMarkets™ 701 Pike Street, Suite 2175, Seattle, WA 98101, United States 1-888-600-6441 Email: [email protected]
Country United States
Categories Health
Tags atherectomy devices market
Last Updated November 7, 2017